Literature DB >> 28615309

The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review.

Leopold Lecheler1, Maximilian Richter2, Daniel P Franzen3, Silvana K Rampini4,5, Marcus Cheetham4,5,6, Josef Jenewein7, Edouard Battegay4,5,6, Albina Nowak4,5.   

Abstract

Patients with acute exacerbated chronic obstructive pulmonary disease (AECOPD) and concurrent depression suffer significant psychological stress and decreased quality of life. The aim of this study was to collate data, guidelines and recommendations from publications on the screening and management of depressive mood disorders in patients hospitalised with AECOPD.We systematically searched four databases for publications reporting screening or management of depression in patients hospitalised for AECOPD. The identification of articles was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.Out of 1494 original articles screened, 35 met all inclusion criteria. These report a prevalence of depression in AECOPD ranging between 9.5% and 85.6%. Some studies report high postadmission mortality rates for depressive AECOPD patients, and higher readmission rates in depressive versus nondepressive AECOPD patients. Importantly, none of the 35 publications included suggestions on the screening and management of depression in AECOPD.Depression and AECOPD frequently co-occur, and this worsens outcomes. Yet we did not find recommendations on management, and few interventional studies. Patients hospitalised with AECOPD should be systematically screened for depression and treatment recommendations should be developed for these patients. Randomised studies on how to screen and treat depression in hospitalised AECOPD are necessary.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28615309     DOI: 10.1183/16000617.0026-2017

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  10 in total

1.  Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.

Authors:  Justyna Pollok; Joep Em van Agteren; Adrian J Esterman; Kristin V Carson-Chahhoud
Journal:  Cochrane Database Syst Rev       Date:  2019-03-06

2.  Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.

Authors:  Justyna Pollok; Joep Em van Agteren; Kristin V Carson-Chahhoud
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

3.  Characteristics and health related quality of life in a population with advanced chronic obstructive pulmonary disease, a cross-sectional study.

Authors:  D G Bove; M Lavesen; B Lindegaard
Journal:  BMC Palliat Care       Date:  2020-06-18       Impact factor: 3.234

4.  Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors:  Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

5.  Advanced nursing practice in COPD exacerbations: the solution for a gap in Switzerland?

Authors:  Gabriela Schmid-Mohler; Christian Clarenbach; Gabi Brenner; Malcolm Kohler; Eva Horvath; Marc Spielmanns; Heidi Petry
Journal:  ERJ Open Res       Date:  2020-06-15

6.  Using Mobile Health Technology to Deliver a Community-Based Closed-Loop Management System for Chronic Obstructive Pulmonary Disease Patients in Remote Areas of China: Development and Prospective Observational Study.

Authors:  Ning Deng; Juan Chen; Yiyuan Liu; Shuoshuo Wei; Leiyi Sheng; Rong Lu; Zheyu Wang; Jiarong Zhu; Jiye An; Bei Wang; Hui Lin; Xiuyan Wang; Yumin Zhou; Huilong Duan; Pixin Ran
Journal:  JMIR Mhealth Uhealth       Date:  2020-11-25       Impact factor: 4.773

7.  Effect of remote mindfulness-based interventions on symptoms of anxiety and depression in patients with chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis.

Authors:  Xiao Wan; Haitao Huang; Dandan Liang; Rui-Ying Jia; Chao-Ran Chen
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

8.  Impact of anxiety and depression on the prognosis of copd exacerbations.

Authors:  Sandra Martínez-Gestoso; María-Teresa García-Sanz; José-Martín Carreira; Francisco-Javier Salgado; Uxío Calvo-Álvarez; Liliana Doval-Oubiña; Sandra Camba-Matos; Lorena Peleteiro-Pedraza; Miguel-Angel González-Pérez; Pedro Penela-Penela; Andrés Vilas-Iglesias; Francisco-Javier González-Barcala
Journal:  BMC Pulm Med       Date:  2022-04-29       Impact factor: 3.320

9.  Mind-Body Exercise for Anxiety and Depression in COPD Patients: A Systematic Review and Meta-Analysis.

Authors:  Zaimin Li; Shijie Liu; Lin Wang; Lee Smith
Journal:  Int J Environ Res Public Health       Date:  2019-12-18       Impact factor: 3.390

10.  Association between cognitive declines and disability in activities of daily living in older adults with COPD: evidence from the China health and retirement longitudinal study.

Authors:  Bingyan Gong; Shaomei Shang; Chao Wu
Journal:  BMJ Open       Date:  2020-10-28       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.